| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 05/10/2007 | US20070105943 Novel antifungal agent containing heterocyclic compound |
| 05/10/2007 | US20070105916 Amphiphilic pyridinium compounds, method of making and use thereof |
| 05/10/2007 | US20070105913 Alkynyl aryl carboxamides |
| 05/10/2007 | US20070105899 Benzene compounds |
| 05/10/2007 | US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors |
| 05/10/2007 | US20070105859 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors |
| 05/10/2007 | US20070105858 Retinoic acid mimetic anilides |
| 05/10/2007 | US20070103060 Platinum complex and light emitting device |
| 05/10/2007 | DE19533711B4 Verfahren zur Herstellung von einem Sulfonimid oder seinem Salz A process for producing a sulfonimide or its salt |
| 05/10/2007 | DE19522167B4 1,2-Difluornaphthalin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen 1,2-difluoronaphthalene-derivatives and their use in liquid crystal mixtures |
| 05/10/2007 | DE102005052847A1 Preparation of N-(1-(hetero)aryl-alk-1-enyl)-acetamide, useful to prepare ketones, comprises reaction of N-(alk-1-enyl)-acetamide with (hetero)aryl chloride in the presence palladium-catalyst, water/ionic liquid and dimethylformamide |
| 05/10/2007 | CA2626504A1 Tricyclo substituted amides as glucokinase modulators |
| 05/10/2007 | CA2626465A1 Process for the preparation of pyridylcarboxylic amides and esters |
| 05/09/2007 | EP1783116A1 2-phenylpyridine derivative |
| 05/09/2007 | EP1783110A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 05/09/2007 | EP1782811A1 Novel antimalaria agent containing heterocyclic compound |
| 05/09/2007 | EP1782689A1 Optically active phthalamide derivative, agricultural or horticultural insecticide, and method of using the same |
| 05/09/2007 | EP1781635A2 Potassium channel inhibitors |
| 05/09/2007 | EP1781630A1 Novel piperidine derivative for the treatment of depression |
| 05/09/2007 | EP1781614A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 05/09/2007 | EP1781597A1 O-aminophenol derivatives and dyes containing these compounds |
| 05/09/2007 | EP1781595A1 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
| 05/09/2007 | EP1781297A1 Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 05/09/2007 | EP1450799B9 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 05/09/2007 | CN1960979A Triazolone derivatives as MMP inhibitors for the treatment of asthma and copd |
| 05/09/2007 | CN1960975A Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP) |
| 05/09/2007 | CN1958571A Method for preparing compound in category of cyanopyridine |
| 05/09/2007 | CN1958568A A kind of compound for preventing or curing infection of helicobacter pylori, preparation method, and application |
| 05/09/2007 | CN1314489C Catalyst for preparing pyridine with the aid of multiple element and its preparation |
| 05/08/2007 | US7214799 Protecting the hydroxyls of 3-hydroxy-4,5-dimethylol-2-picoline, reacting the 4-methylol group with an imide (especially potasssium phthalimide), cleaving the imide group to deprotect the amine group, and deprotecting the remaining hydroxy groups |
| 05/08/2007 | US7214798 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; analgesics |
| 05/08/2007 | US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
| 05/08/2007 | US7214714 for treatment of renal diseases, cerebrovascular diseases and circulatory diseases |
| 05/08/2007 | US7214712 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 05/08/2007 | US7214710 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 05/08/2007 | US7214697 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| 05/08/2007 | US7214693 Contraceptices; hormone sensitivity diseases; antidepressants; sexual disorders ; osteoporosis; alopecia |
| 05/08/2007 | US7214682 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 05/08/2007 | US7214681 Tri(cyclo) substituted amide compounds |
| 05/08/2007 | US7214678 Having antiinflammatory, anti-pyretic and anti-diarrheal properties |
| 05/08/2007 | US7214677 Benzamide, heteroarylamide and reverse amides |
| 05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 05/08/2007 | CA2325741C Urea derivatives having tnf- .alpha. production inhibitory effects |
| 05/08/2007 | CA2310593C Metalloproteinase inhibitors |
| 05/08/2007 | CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/03/2007 | WO2007050612A1 2-amino-3,4-dihydro-pyrido[3,4-d]pyrimidine derivatives useful as inhibitors of beta-secretase (bace) |
| 05/03/2007 | WO2007050347A1 Potassium channel inhibitors |
| 05/03/2007 | WO2007049736A1 Concentration crystallizer and method |
| 05/03/2007 | WO2007049371A1 Bister-pyridine-type monomer and process for producing the same, polymer material derived from said monomer and process for producing the same, and electrochromic element |
| 05/03/2007 | WO2007048557A1 Protease inhibitors |
| 05/03/2007 | WO2007048556A1 Heterocyclic amide derivatives useful as microbiocides |
| 05/03/2007 | WO2007048265A1 Organic compounds |
| 05/03/2007 | WO2007027528A3 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases |
| 05/03/2007 | WO2006081276A8 3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity |
| 05/03/2007 | WO2006040527A8 Process for making phenoxy benzamide compounds |
| 05/03/2007 | WO2005075418A3 N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them |
| 05/03/2007 | US20070099965 2-Pyridinylethylbenzamide derivatives |
| 05/03/2007 | US20070099962 5,6-Dihydropyrin-2-one compounds useful as inhibitors of thrombin |
| 05/03/2007 | US20070099961 Method for producing bactericidal pyridine compound and bactericidal pyridine compound |
| 05/03/2007 | US20070099956 Nitrogen-containing heterocyclic derivatives having 2, 6-disubstituted styryl |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099909 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
| 05/03/2007 | US20070099895 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 05/03/2007 | US20070099893 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 05/03/2007 | US20070099826 Treatment of diseases associated with the egr-1 enhancer element |
| 05/03/2007 | DE102005052540A1 Preparing mesomer betaine, useful to increase magnetic character in polymers, comprises extracting leaf phenols from pomegranate leaves, synthesizing N-(dihydroxyphenyl)-pyridinium-chloride as monomer and processing with plastics |
| 05/03/2007 | CA2626312A1 Heterocyclic amide derivatives useful as microbiocides |
| 05/03/2007 | CA2625541A1 Ppar modulating biaromatic compounds |
| 05/02/2007 | EP1780201A2 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1778658A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 05/02/2007 | EP1778644A2 Method of coloring with capped diazotized compound and coupling component |
| 05/02/2007 | EP1778627A1 Method for producing enantiomeric form of 2, 3-diaminopropionic acid derivatives |
| 05/02/2007 | EP1778624A1 Tyrosine derivatives as ppar-gamma-modulators |
| 05/02/2007 | EP1458685B1 Substituted phenyl derivatives |
| 05/02/2007 | EP1358184B1 N-(3,3-Dimethylindolin-6-yl){2-[(4-pyridylmethyl)amino}(3-pyridyl)}carboxamide and pharmaceutical compositions thereof. |
| 05/02/2007 | EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 05/02/2007 | EP1098879B1 Processes for producing highly pure nicotinamide |
| 05/02/2007 | CN1956977A Pharmaceutical dosage forms and compositions of 5-HT1a receptor antagonists |
| 05/02/2007 | CN1956959A Therapeutic compounds: pyridine N oxide scaffold |
| 05/02/2007 | CN1956958A Aminopyridine derivatives as selective dopamine d3 agonists |
| 05/02/2007 | CN1956957A Method for the production of a-chloroalkylpyridyl ketones and/or the hydrochlorides thereof |
| 05/02/2007 | CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/02/2007 | CN1313472C Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such |
| 05/02/2007 | CN1313464C Substituted alkylamine derivatives, preparing method thereof, composition comprising same and use thereof |
| 05/01/2007 | US7211695 Trans-1,4-bis{N-[2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethyl]amino}cyclohexane from aminating a dihydroxymethyl phenyl ketone with a diaminophenylene compound and a reducing agent; treating respiratory diseases, asthma, bronchitis, nervous system injury, premature labor |
| 05/01/2007 | US7211685 Carboxy group, nitro group, tert-butoxycarbonylamino group or benzyloxycarbonylamino substituted naphthalene: osteoporosis, hypoparathyreosis, osteosarcoma, periodontal disease, bone fracture, steoarthrosis, chronic rheumatoid arthritis, Paget's disease, humoral hypercalcemia |
| 05/01/2007 | US7211680 (5Z,7E,22E)-(1S,3R,24R)-25-phenyl-26,27-cyclo-9,10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; treating hyperprolifierative diseases of the skin, tumor diseases and precancerous stages, auto-immune diseases, rejection reactions in the case of autologous, allogenic or xenogenic transplants, AIDS |
| 05/01/2007 | US7211591 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient |
| 05/01/2007 | US7211579 NK-1 receptor antagonists |
| 05/01/2007 | US7211575 Methods of treating cytokine mediated diseases |
| 05/01/2007 | CA2301590C 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 05/01/2007 | CA2176960C Novel carbamate compounds and processes for preparing the same |
| 05/01/2007 | CA2162630C Sulfonamides |
| 05/01/2007 | CA2143636C Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
| 05/01/2007 | CA2138675C Catecholamine surrogates useful as .beta.3 agonists |
| 05/01/2007 | CA2124647C Poly (pyridinium salts) |
| 04/26/2007 | WO2007047447A2 Diuretic-like compound analogs useful for regulation of central nervous system disorders |
| 04/26/2007 | WO2007047306A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 04/26/2007 | WO2007046616A1 Process for preparation of chiral amlodipine gentisate |